The FDA has delayed the PDUFA date for Moderna's RSV vaccine, Moderna announced Friday morning. The delay likely won't push ...

The FDA will decide this weekend whether to greenlight Moderna’s RSV vaccine, potentially giving the company its first ...

Sanofi is handing Novavax $500 million upfront to bring the biotech’s Covid-19 vaccine into the fold, with dual goals of ...

Maze Therapeutics has found a new buyer for its Pompe disease candidate, five months after scrutiny from the Federal Trade ...

Lykos Ther­a­peu­tics is on a jour­ney to get the first MD­MA-as­sist­ed PTSD ther­a­py ap­proved by the FDA, and the biotech ...

Macro­Gen­ics re­port­ed on Thurs­day af­ter­noon that three pa­tients died in a mid-stage tri­al of its an­ti­body-drug ...

As the head of the trade group BIO and a parent to children with a rare disease, John Crowley is personally and ...

An advisory committee will convene November 14 and 15 to vote on whether Duchenne muscular dystrophy should be included in a ...

Bluebird bio’s stock $BLUE jumped over 20% on Thursday following its first-quarter earnings release and the announcement of ...

In the lead-up to the likely approval of Geron’s drug to treat certain types of anemia, drug pricing watchdog the Institute ...

Takeda is shuttering its San Diego research site, the company confirmed to Endpoints News. The company told employees on ...

Charles River Laboratories’ manufacturing arm delivered a large revenue jump in the first quarter of the year owing to an ...